The patient who was hospitalized after receiving Intellia Therapeutics’ CRISPR therapy nex-z has died. | The patient who was ...
Rising rural-to-urban migration, intensifying climate extremes, and accelerating degradation of natural resources, ...
WEF report highlights how AI, robotics, and nanotech are transforming agriculture, citing case studies from India. Read more!
Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First Line (1L) Consolidation in Large B-Cell Lymphoma (LBCL) ALPHA3 ...
Asianet Newsable on MSN
Eli Lilly Stock Defies Trump’s GLP-1 Pricing Pressure With 6-Day Rally As Wall Street Cheers FDA Boost And New Weight-Loss Drug Data
Bank of America Securities called Lilly’s GLP-1 pricing deal “probably a good tradeoff overall,” keeping a ‘Buy’ rating and ...
Awaiting FDA clinical hold letter on MAGNITUDE and MAGNITUDE-2 clinical trials of nex-zPresenting longer-term Phase 1 clinical data of nex-z for ATTR-CM on November 10 at AHA 2025; previously ...
Get the latest on Intellia Therapeutics’ Q3 2025 earnings: clinical hold impacts, nex-z safety updates, lonvo-z progress, and financial outlook.
Biopharmaceuticals: Redefining the Future of Modern MedicineThe Global Bio Pharmaceuticals Market is valued at USD 421.58 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback